Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 may worsen hair loss, and Nourkrin® could be a safe treatment option, but more research is needed.

Long COVID patients may have hormonal imbalances linked to their symptoms.

The letter suggests testosterone replacement therapy might worsen COVID-19 outcomes.

A woman lost over 80% of her hair due to a condition called telogen effluvium after having COVID-19.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Severe male balding may increase the risk of serious COVID-19, and treatments that reduce androgens or block a specific enzyme might help protect these individuals.

The conclusion is that certain genetic factors and blood types may affect COVID-19 severity, but changes in ACE2 and TMPRSS2 genes are not clearly linked to it.

Certain genes and nutrients like vitamin D, zinc, and omega fatty acids affect COVID-19 severity and infection risk.

Healthcare workers in Turkey experienced more skin problems due to frequent handwashing and wearing masks and gloves during the COVID-19 outbreak.

Men have worse COVID-19 outcomes than women due to genetic and hormonal differences.

Long COVID is more common in those with severe initial infections, but not linked to blood group.

Nursing staff's mental health was affected during the COVID-19 pandemic.

Key genes linked to immune response are upregulated in hair follicles and skin tissues in chronic discoid lupus erythematosus.

Using fat stem cells and blood cell-rich plasma together improves healing in diabetic wounds by affecting cell signaling.

Removing anthrax toxin receptor 1 in pigs prevents Senecavirus A infection and causes a rare disease similar to GAPO syndrome.

Teprotumumab for thyroid eye disease commonly causes fatigue, brittle nails, dry eyes, hair loss, muscle spasms, and dry mouth, with rare serious events like blood clots.

Proper hygiene, adequate sleep, and self-care can reduce common skin diseases.

Balding might help identify men at higher risk for severe COVID-19, but more research is needed.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Long COVID patients have more health issues than non-infected people.

The study suggests pandemic stress might worsen or trigger hair loss problems.

A COVID-19 patient had severe and long-lasting skin issues and unusual hair loss.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

COVID-19 can cause rashes and worsen existing skin conditions, and behaviors like frequent hand-washing can lead to hand dermatitis.

About a quarter of the participants experienced hair loss after COVID-19 vaccination.

COVID-19 can cause various skin symptoms that usually improve with proper treatment.

Shi-Bi-Man helps hair regrowth by activating the FGF pathway in cells.